Patient Safety in Surgery

Patient Safety in Surgery is a fully open access journal published by BioMed Central, part of Springer Nature, that reports research on the safety and quality of surgical care. It appeared for the first time on 7 November 2007 and now issues one volume per year, so that volume 20 is dated December 2026. The metrics on the journal page give a 2025 impact factor of 3.3, a five-year figure of 3.0 and a median of five days from submission to first decision.《手术安全》是 BioMed Central 出版的一份全开放获取期刊，隶属 Springer Nature，刊发外科诊疗安全与质量方面的研究。该刊 2007 年 11 月 7 日首次出版，如今每年一卷，2026 年 12 月出到第 20 卷。刊页所列指标为 2025 年影响因子 3.3，五年影响因子 3.0，投稿至首次决定的中位数为 5 天。

Scope

• The journal publishes articles on all issues related to safety and quality of patient care in surgery and surgical subspecialties.该刊发表面向外科及各外科亚专科患者照护安全与质量各个议题的文章。

• It offers a scientific platform where specialists from all surgical fields and other healthcare professionals can report, discuss, debate and critically review errors, complications and other safety issues in the management of patients undergoing surgical procedures.该刊搭建一个科学平台，让各外科领域的专科医师与其他医疗专业人员报告，探讨，辩论并批判性审视外科手术患者管理中的差错，并发症与其他安全问题。

• Morbidity and mortality among surgical patients are in large part preventable, and the journal holds that understanding the causes of adverse events is the key to improving their management.外科患者的发病与死亡在很大程度上可以预防，该刊认为，厘清不良事件的成因正是改善其处置的关键。

• The causes range from individual errors in surgical technique and perioperative decision making to system errors in hospitals, and extend as far as to general healthcare issues in politics.这些成因从手术技术与围手术期决策中的个人差错，一路延伸到医院层面的系统错误，以及政治层面的医疗卫生议题。

• An evidence-based approach to quality improvement in surgical care has to include an analysis of the incidence and pattern of adverse events.以外科照护质量改进为核心的循证路径，必须包含对不良事件发生率与形态的分析。

• Procedures that did not turn into an adverse event but carried a strong potential to do so are wanted as well, on the argument that such cases risk being neglected or trivialised instead of being reported and reviewed as true complications.那些虽未酿成不良事件却潜藏高度风险的操作同样在征稿之列，理由是这类病例若不被上报并作为真正的并发症加以审视，便有被忽视或轻描淡写的危险。

• The editor-in-chief describes the journal as welcoming original research, reviews and case reports, together with debate and hypothesis papers on patient safety.主编把该刊的收稿范围说成欢迎原创研究，综述与病例报告，以及围绕病人安全的辩论与假说论文。

• The types of article that the submission guidelines set out are research, review, case report and brief report.投稿指南列出的稿件类型有研究，综述，病例报告与简报。

• The editorial board is drawn from more than a dozen countries, among them the United States, Germany, Switzerland, the United Kingdom, Sweden, the Netherlands, New Zealand, Colombia, Italy, Brazil, China, Israel, India and Australia.编委成员来自十余个国家，其中有美国，德国，瑞士，英国，瑞典，荷兰，新西兰，哥伦比亚，意大利，巴西，中国，以色列，印度与澳大利亚。

• Two statistical advisors sit alongside the editors, one at the Institute for Quality and Efficiency in Health Care in Cologne and one at the Bay Pines VA Healthcare System in Florida.编委之外另设两位统计顾问，一位任职于科隆的质量与医疗效率研究所，另一位任职于佛罗里达州的贝派恩斯退伍军人医疗系统。

• Articles are published open access under a Creative Commons Attribution Non-Commercial No Derivatives licence or a Creative Commons Attribution licence, and authors keep their copyright.文章以开放获取方式发表，采用知识共享署名非商业性禁止演绎许可协议，或知识共享署名许可协议，著作权仍归作者所有。

• The article processing charge for an accepted paper is 2390 pounds sterling, 3290 US dollars or 2790 euros, and Springer Nature offers waivers and discounts to authors in the world's lowest income countries.被接收论文的文章处理费为 2390 英镑，3290 美元或 2790 欧元，Springer Nature 为世界上收入最低国家的作者提供减免与折扣。

History

• The first issue appeared on 7 November 2007, opened by an editorial from (Philip F Stahel), (Pierre-Alain Clavien), (Dieter Hahnloser) and (Wade R Smith) announcing a new journal devoted to safety in surgical care.创刊号于 2007 年 11 月 7 日出版，开篇是（Philip F Stahel），（Pierre-Alain Clavien），（Dieter Hahnloser）与（Wade R Smith）撰写的社论，宣布一份献身外科病人安全的新刊诞生。^[1]

• BioMed Central, the publisher of the journal, was itself founded in 2000, when it opened its titles to every reader and made the open access model a sustainable way to publish.该刊出版方 BioMed Central 自身创办于 2000 年，那一年它把旗下刊物向每一位读者开放，并让开放获取模式成为可以长期运行的出版方式。

• BMC has since grown into a portfolio of more than 300 peer-reviewed journals, supported by over 23000 editors and read by six million people every month.此后 BMC 发展为拥有 300 余种同行评审期刊的出版品牌，编审队伍超过 23000 人，每月读者约 600 万。

• In 2026 the BMC journal platform moved to Springer Nature Link, so the journal's own pages now carry the Springer Nature masthead while the BioMed Central imprint survives in the copyright line.2026 年 BMC 的期刊平台迁至 Springer Nature Link，该刊页面因此改用 Springer Nature 的刊头，而 BioMed Central 的字样仍留在版权行里。

• Publication has run continuously ever since the launch, and one annual volume has always been the unit, with volume 1 dated December 2007, volume 10 dated December 2016 and volume 20 dated December 2026.自创刊起该刊连续出版，年度卷一直是出版单位，2007 年 12 月为第 1 卷，2016 年 12 月为第 10 卷，2026 年 12 月为第 20 卷。

• The second volume, dated 2008, already carried more than thirty articles under a single issue label, a pattern that matches the catalogue note that articles are added consecutively to the current annual volume.第 2 卷出版于 2008 年，仅以一个期号标注就已收录三十余篇文章，这与编目记录中文章连续编入当年度卷的说法吻合。

• In 2008 (Philip F Stahel) used the journal to argue for formal readbacks in surgery, drawing lessons from aviation safety.2008 年，（Philip F Stahel）借该刊提出外科应引入正式的复诵核对，并向航空安全取经。^[2]

• The journal has kept its fully open access model throughout, and the 2025 Journal Citation Reports record every one of its articles as gold open access.该刊始终维持全开放获取模式，2025 年期刊引证报告把其全部文章记为黄金开放获取。

• Its impact factor has moved between 2.6 in 2023, 2.1 in 2024 and 3.3 in 2025, and the journal page reported 554.8 thousand downloads in the same year.该刊影响因子在 2023 年的 2.6，2024 年的 2.1 与 2025 年的 3.3 之间起落，刊页同一年记录的下载量为 55.48 万次。

• The journal page now carries a call for papers on cutting edge innovation for patient safety in trauma surgery, with submissions closing on 16 January 2027.该刊页面目前挂着一项专题征稿，主题是创伤外科病人安全的前沿创新，投稿截止时间为 2027 年 1 月 16 日。

• Recent issues mix systematic reviews with research on postoperative complications, brief reports on telemedicine follow-up after day surgery and a review of moral distress in neurosurgical practice.近期各期把系统综述与术后并发症研究放在一起，还收有日间手术后远程医疗随访的简报，以及神经外科执业中道德困扰的综述。

Editors

• (Philip F Stahel) is editor-in-chief of the journal and is based at Banner Wyoming Medical Center in Casper, United States.（Philip F Stahel）担任该刊主编，任职于美国卡斯珀的班纳怀俄明医疗中心。

• (Navid Ziran) serves as managing editor from St. Joseph's Hospital and Medical Center in Phoenix, United States.（Navid Ziran）任执行编辑，来自美国菲尼克斯的圣约瑟夫医院与医疗中心。

• Four senior editors emeriti are listed, among them (Pierre-Alain Clavien) of University Hospital of Zurich and (George Youngson) of the Royal College of Surgeons of Edinburgh.刊物列有四位卸任资深编辑，其中包括苏黎世大学医院的（Pierre-Alain Clavien）与爱丁堡皇家外科医学院的（George Youngson）。

• Twenty-five associate editors cover the surgical fields, from (Walter Biffl) of Scripps Memorial Hospital to (Martin A Makary) of Johns Hopkins Hospital and (Charles Vincent) of the University of Oxford.二十五位副主编覆盖不同外科领域，从斯克里普斯纪念医院的（Walter Biffl）到约翰霍普金斯医院的（Martin A Makary）与牛津大学的（Charles Vincent）。

• The wider editorial board lists 38 members, and among them are (Jiandong Hao) of the Third Hospital of Hebei Medical University in Shijiazhuang and (Sebastian Weckbach) of NeuroSpineZurich.编委名录列出 38 位成员，其中有石家庄河北医科大学第三医院的（Jiandong Hao）与苏黎世 NeuroSpine 的（Sebastian Weckbach）。

• Two statistical advisors, (Stefan Sauerland) of the Institute for Quality and Efficiency in Health Care in Cologne and (Allison E Williams) of the Bay Pines VA Healthcare System, support the editors.两位统计顾问为该刊提供支持，一位是科隆的质量与医疗效率研究所的（Stefan Sauerland），另一位是贝派恩斯退伍军人医疗系统的（Allison E Williams）。

• The journal runs a single-anonymous peer review system, so reviewers see the names and affiliations of the authors while the reports they send back stay anonymous.该刊实行单匿名评审，审稿人能看到作者姓名与单位，而他们提交的评审意见对作者保持匿名。

• Two or more independent experts assess each manuscript on the soundness of the research method, the originality of the work and the clarity of the writing, and the editors base their decision on those reports, consulting the board when needed.每份稿件由两位以上独立专家按研究方法的可靠程度，工作的原创性与行文的清晰度评审，编辑依据这些评审意见作出决定，必要时征询编委意见。

• Authors may propose reviewers in the cover letter and should give institutional email addresses, an ORCID or a Scopus identifier so that the editor can check who they are, and falsified names lead to rejection.作者可在附信中推荐审稿人，宜给出机构邮箱，ORCID 或 Scopus 标识以便编辑核实身份，伪造姓名将导致稿件被拒。

• Reviewers and editors have to declare competing interests, and either of them can be excluded from the review process when such an interest exists.审稿人与编辑均须申报利益冲突，存在此类利益时双方都可被排除在评审流程之外。

• Every submission is handled under the same editorial policies, and manuscripts sent to collections or special issues receive no different treatment.所有投稿都在同一套编辑政策下处理，提交给专辑或专号的稿件也不受不同对待。

• Papers that are not accepted can be moved to another journal in the Springer Nature portfolio through the transfer service, which spares authors the work of reformatting.未被接收的稿件可经稿件转投服务转到 Springer Nature 旗下另一份期刊，作者无需重新排版。